Welcome to SmartBytes

Brokers and Consultants Play Different Roles. RxLogic Supports Both.

Whether the engagement centers on marketplace selection or strategic analysis, pharmacy benefit recommendations must be translated into accurate, traceable workflows.

In employee benefits, the line between a broker and a consultant isn’t always clear. Both may help employers evaluate PBMs, review contract terms and manage vendor relationships. The difference usually comes down to the main focus of their work rather than the title they use.

RxLogic delivers compliant pharmacy benefit operational execution through a modern technology platform purpose-built for claim pricing decisions, financial workflows and regulatory compliance at scale. Its independent, cloud-native platform enables pharmacy benefit organizations to operationalize complex pricing, rebate and regulatory requirements directly within the claim lifecycle. This reflects RxLogic’s role in decision execution rather than decision support alone. Brokers and consultants guide the client, while RxLogic executes operational workflows tied to claim pricing, rebate and compliance processes.

The Roles Differ in Scope and Focus

A broker generally leads the marketplace process. That may include identifying suitable PBM or pharmacy benefit options, comparing proposals, negotiating arrangements and helping the client manage a renewal or transition.

A consultant more often begins with the plan’s objectives and data. The work may involve examining benefit design, pricing, rebate arrangements, utilization and vendor performance before recommending a broader strategy or changes to an existing program.

These responsibilities are not mutually exclusive. Many advisory firms combine brokerage and consulting services and professionals in either role may remain involved throughout the relationship. The meaningful distinction is whether the engagement centers primarily on securing and managing a solution or analyzing what the plan needs and how well its strategy is performing.

Brokers Need a Clear Path from Selection to Implementation

Choosing an arrangement doesn’t ensure that every component will function as negotiated once claims begin processing. Pricing rules, network terms, rebate provisions and financial requirements must operate together without creating unnecessary work for the client.

RxLogic helps carry the selected solution into production through modular technology supporting claims adjudication, pharmacy networks, rebate administration, prior authorization, discount programs and financial workflows. Its API-first architecture connects with external systems and benefit partners, allowing organizations to configure the capabilities that fit each client instead of forcing every plan into the same operating model.

For a broker, that flexibility helps preserve the intent of the arrangement from procurement through implementation and ongoing service.

Consultants Need Evidence to Evaluate Performance

A consultant’s analysis doesn’t end when the client approves a strategy. The consultant must be able to determine whether plan rules, financial arrangements and vendor commitments are producing the intended results.

RxLogic supports that evaluation by maintaining detailed records of the logic and financial components associated with pharmacy claims. Claim-level pricing, NDC-11 rebate data, network assignment and configurable reporting provide a clearer basis for reviewing performance. Traceable workflows also reduce the need to reconstruct decisions from disconnected systems when questions or audits arise.

As disclosure and fiduciary expectations grow, this visibility helps clients and their consultants examine how pharmacy benefit outcomes were produced and identify where the program may require refinement.

Execution Keeps Advice Connected to Outcomes

RxLogic does not replace the judgment of either advisor. Brokers and consultants continue to guide selection, strategy and client decisions. RxLogic provides tools, automation, visibility and transparency to support compliance strategies without assuming compliance responsibility. Legal, fiduciary and contractual decisions remain with the appropriate parties.

RxLogic performs a separate but complementary function. The platform configures approved requirements into operational workflows, applies the relevant logic during processing and preserves a record of each outcome. Its independence supports that position. RxLogic doesn’t own a pharmacy, retain rebates, steer claims or monetize spread pricing.

The result is a clearer division of responsibility. Advisors help clients determine what will serve their needs. As a technology company, RxLogic provides the platform that carries out that recommendation consistently and keeps it measurable as requirements change.

Connect with RxLogic to learn how compliant pharmacy benefit operational execution can help translate the strategies brokers and consultants recommend into everyday workflows.


RxLogic LinkedIn

Past Issues

From the RxLogic Blog

Tech Blog

Proprietary Technology Matters in Pharmacy Benefit Operations

As pharmacy benefit operations grow more complex, the question of who built and controls the underlying technology is becoming harder to ignore. In our blog, we break down the difference between technology partners who own their platform and those who license, resell or repackage someone else's infrastructure.

We explore why proprietary ownership of the adjudication engine, application logic and cloud infrastructure gives organizations like RxLogic the ability to move faster on configuration, integrations and product development, without waiting on a third party's roadmap. As transparency expectations and regulatory pressure continue to rise, we discuss why the strength of a technology partner's foundation determines how well it can keep pace with what pharmacy benefit stakeholders need next.

Big3

Big Three PBM Use is Falling. Alternative Models Must Be Ready To Deliver

Switching pharmacy benefit managers is a major undertaking, but new survey data shows more purchasers are willing to consider it. In this blog, we break down findings from the Pulse of the Purchaser 2026 Survey, which shows Big Three PBM use dropped from 63.4% to 54.3% year over year, with the steepest decline among employers with fewer than 1,000 employees.

We discuss why that movement may only be the beginning. Among current Big Three clients, 55.7% said they're considering a change within the next one to three years, and interest climbs with organization size. We dive into what it takes for alternative PBMs to capture that opportunity, including the operational technology needed to execute complex implementations and serve larger, more demanding purchasers reliably.

RxLogic in the News

 RxLogic and Healthesystems Partner to Advance Workers’ Compensation PBM Innovation 


RxLogic and Epidaurus Health Bring Automated Prior Authorization Live on an Independent Adjudication Platform

RxLogic on the Road

RxLogic is Heading to the Self-Insurance Institute of America National Conference in Less Than a Month

With just weeks to go, RxLogic is finalizing plans for the Self-Insurance Institute of America National Conference, October 11–13 at the JW Marriott Desert Ridge in Phoenix, AZ. RxLogic Lori Daugherty, CEO, RxLogic, will join the panel "Upend the Status Quo: Think Creatively About Medical & Pharmacy Benefits" on Monday, October 12, from 1:30–2:45 p.m. MST in Grand Sonoran E, discussing why PBM evaluation must extend beyond pricing models to the infrastructure behind claims adjudication, rebate administration and financial reporting.

Lori will be joined on-site at Booth 207 and 209 by Billy Buckles, SVP of Business Development & Implementation, Doug Benson, VP of Strategic Account Planning & Success, Ann Beal, SVP of Specialty Pharmacy Services and Marc Albers, SVP of Strategy. Stop by to talk through how RxLogic’s technology helps self-insured employers move from promises of transparency to proof.

To set up time with RxLogic in Phoenix, reach out to Jessica Rodriguez at jrodriguez@rxlogic.com.